S100A12 and COVID-19: The upregulated serum levels of S100A12 and OSM are characteristic for patients with severe COVID-19 (23, 28), but as they are overexpressed at sites of inflammation, their serum levels correlate with the disease activity of many inflammatory diseases, including sepsis and other pulmonary infections (29, 30).